Skin reaction and regeneration after single sodium lauryl sulfate exposure stratified by filaggrin genotype and atopic dermatitis phenotype

British Journal of Dermatology

Volumn 172, Issue 6, 2015, Pages 1519-1529

  Bandier, J ^a   Carlsen, B C ^a   Rasmussen, M A ^b   Petersen, L J ^c   Johansen, J D ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; FILAGGRIN; INTERMEDIATE FILAMENT PROTEIN; IRRITANT AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ATOPIC DERMATITIS; CASE CONTROL STUDY; CONTROLLED STUDY; CONVALESCENCE; DRUG EXPOSURE; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHENOTYPE; PRIORITY JOURNAL; REGENERATION; SKIN IRRITATION; SKIN MANIFESTATION; SKIN WATER LOSS; ADOLESCENT; DOSE RESPONSE; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENETICS; IRRITANT DERMATITIS; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; RANDOMIZATION; THERMOREGULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; DERMATITIS, IRRITANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOTYPE; HUMANS; INTERMEDIATE FILAMENT PROTEINS; IRRITANTS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; RANDOM ALLOCATION; REGENERATION; SKIN PHYSIOLOGICAL PHENOMENA; SODIUM DODECYL SULFATE; WATER LOSS, INSENSIBLE; YOUNG ADULT;

EID: 84930382037     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13651     Document Type: Article

References (44)

1. Sandilands A, Sutherland C, Irvine AD, McLean WH,. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci 2009; 122: 1285-94.
2. McGrath JA,. Filaggrin and the great epidermal barrier grief. Australas J Dermatol 2008; 49: 67-74.
3. McGrath JA, Uitto J,. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med 2008; 14: 20-7.
4. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al,. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 2007; 39: 650-4.
5. Smith FJ, Irvine AD, Terron-Kwiatkowski A, et al,. Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet 2006; 38: 337-42.
6. Gruber R, Janecke AR, Fauth C, et al,. Filaggrin mutations p. R501X and c.2282del4 in ichthyosis vulgaris. Eur J Hum Genet 2006; 15: 179-84.
7. de Jongh CM, Khrenova L, Verberk MM, et al,. Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. Br J Dermatol 2008; 159: 621-7.
8. de Jongh CM, John SM, Bruynzeel DP, et al,. Cytokine gene polymorphisms and susceptibility to chronic irritant contact dermatitis. Contact Dermatitis 2008; 58: 269-77.
9. Tupker RA, Willis C, Berardesca E, et al,. Guidelines on sodium lauryl sulfate (SLS) exposure tests. Contact Dermatitis 1997; 37: 53-69.
10. Tupker RA, Bunte EE, Fidler V, et al,. Irritancy ranking of anionic detergents using one-time occlusive, repeated occlusive and repeated open tests. Contact Dermatitis 1999; 40: 316-22.
11. Schnuch A, Carlsen BC,. Genetics and individual predispositions in contact dermatitis. In: Contact Dermatitis (, Johansen JD, Frosch P, Lepoittevin J-P, eds), 5th edn. Berlin Heidelberg: Springer-Verlag, 2011; 13-42.
12. Malten KE,. Thoughts on irritant contact dermatitis. Contact Dermatitis 1981; 7: 238-47.
13. Mildner M, Jin J, Eckhart L, et al,. Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol 2010; 130: 2286-94.
14. Scharschmidt TC, Man MQ, Hatano Y, et al,. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009; 124: 496-506.
15. Agner T,. Susceptibility of atopic dermatitis patients to irritant dermatitis caused by sodium lauryl sulphate. Acta Derm Venereol 1991; 71: 296-300.
16. Tupker RA, Pinnagoda J, Coenraads PJ, Nater JP,. Susceptibility to irritants: role of barrier function, skin dryness and history of atopic dermatitis. Br J Dermatol 1990; 123: 199-205.
17. Jungersted JM, Scheer H, Mempel M, et al,. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy 2010; 65: 911-18.
18. Angelova-Fischer I, Mannheimer AC, Hinder A, et al,. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling. Exp Dermatol 2011; 20: 351-6.
19. Perusquía-Ortiz AM, Oji V, Sauerland MC, et al,. Complete filaggrin deficiency in ichthyosis vulgaris is associated with only moderate changes in epidermal permeability barrier function profile. J Eur Acad Dermatol Venereol 2013; 27: 1552-8.
20. Angelova-Fischer I, Dapic I, Hoek AK, et al,. Skin barrier integrity and natural moisturising factor levels after cumulative dermal exposure to alkaline agents in atopic dermatitis. Acta Derm Venereol 2014; 94: 640-4.
21. Torma H, Lindberg M, Berne B,. Skin barrier disruption by sodium lauryl sulfate-exposure alters the expressions of involucrin, transglutaminase 1, profilaggrin, and kallikreins during the repair phase in human skin in vivo. J Invest Dermatol 2008; 128: 1212-19.
22. Williams HC, Burney PG, Hay RJ, et al,. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131: 383-96.
23. Meldgaard M, Szecsi PB, Carlsen BC, et al,. A novel multiplex analysis of filaggrin polymorphisms: a universally applicable method for genotyping. Clin Chim Acta 2012; 413: 1488-92.
24. Pinnagoda J, Tupkek RA, Agner T, Serup J,. Guidelines for transepidermal water loss (TEWL) measurement. Contact Dermatitis 1990; 22: 164-78.
25. Smilde AK, Jansen JJ, Hoefsloot HC, et al,. anova -simultaneous component analysis (ASCA): a new tool for analyzing designed metabolomics data. Bioinformatics 2005; 21: 3043-8.
26. Bandier J, Johansen JD, Petersen LJ, Carlsen BC,. Skin pH, atopic dermatitis, and filaggrin mutations. Dermatitis 2014; 25: 127-9.
27. Rystedt I,. Hand eczema and long-term prognosis in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1985; 117: 1-59.
28. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al,. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-6.
29. Irvine AD, McLean WH, Leung DY,. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315-27.
30. Jakasa I, Koster ES, Calkoen F, et al,. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol 2011; 131: 540-2.
31. Mocsai G, Gaspar K, Nagy G, et al,. Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis. Br J Dermatol 2014; 170: 617-24.
32. van der Valk PG, Nater JP, Bleumink E,. Vulnerability of the skin to surfactants in different groups of eczema patients and controls as measured by water vapour loss. Clin Exp Dermatol 1985; 10: 98-103.
33. Nemoto-Hasebe I, Akiyama M, Nomura T, et al,. Clinical severity correlates with impaired barrier in filaggrin-related eczema. J Invest Dermatol 2009; 129: 682-9.
34. Kezic S, O'Regan GM, Yau N, et al,. Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy 2011; 66: 934-40.
35. Agner T, Serup J,. Sodium lauryl sulphate for irritant patch testing-a dose-response study using bioengineering methods for determination of skin irritation. J Invest Dermatol 1990; 95: 543-7.
36. Petersen LJ,. Direct comparison of laser Doppler flowmetry and laser Doppler imaging for assessment of experimentally-induced inflammation in human skin. Inflamm Res 2013; 62: 1073-8.
37. Petersen LJ, Lyngholm AM, Arendt-Nielsen L,. A novel model of inflammatory pain in human skin involving topical application of sodium lauryl sulfate. Inflamm Res 2010; 59: 775-81.
38. Pellerin L, Henry J, Hsu CY, et al,. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin Immunol 2013; 131: 1094-102.
39. Visser MJ, Landeck L, Campbell LE, et al,. Impact of atopic dermatitis and loss-of-function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis. Br J Dermatol 2013; 168: 326-32.
40. Thyssen JP, Carlsen BC, Menné T, et al,. Filaggrin null mutations increase the risk and persistence of hand eczema in subjects with atopic dermatitis: results from a general population study. Br J Dermatol 2010; 163: 115-20.
41. Bandier J, Ross-Hansen K, Carlsen BC, et al,. Carriers of filaggrin gene (FLG) mutations avoid professional exposure to irritants in adulthood. Contact Dermatitis 2013; 69: 355-62.
42. Howell MD, Kim BE, Gao P, et al,. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immun 2009; 124 (3 Suppl. 2): R7-12.
43. Nicholson M, Willis CM,. The influence of patch test size and design on the distribution of erythema induced by sodium lauryl sulfate. Contact Dermatitis 1999; 41: 264-7.
44. Agner T, Serup J,. Individual and instrumental variations in irritant patch-test reactions-clinical evaluation and quantification by bioengineering methods. Clin Exp Dermatol 1990; 15: 29-33.